Breast cancer patients with a negative axillary ultrasound may have clinically significant nodal metastasis Stephen KeelanAnna HeeneyArnold Hill Review 10 April 2021 Pages: 303 - 310
New horizons in imaging and surgical assessment of breast cancer lymph node metastasis Firouzeh ArjmandiAnn MootzBasak Dogan Review 12 May 2021 Pages: 311 - 322
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review D. TrapaniF. GiuglianoG. Curigliano Review 27 May 2021 Pages: 323 - 337
SETD2 alterations and histone H3K36 trimethylation in phyllodes tumor of breast Julia Y. TsangSui-Ting LaiGary M. Tse Preclinical study 12 April 2021 Pages: 339 - 347
NSDHL promotes triple-negative breast cancer metastasis through the TGFβ signaling pathway and cholesterol biosynthesis Mengting ChenYang ZhaoWei Jin Preclinical study 16 April 2021 Pages: 349 - 362
Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer Anjana BhardwajMatthew D. EmburyIsabelle Bedrosian Preclinical study Open access 24 April 2021 Pages: 363 - 374
FASN inhibition as a potential treatment for endocrine-resistant breast cancer Aleksandra GruslovaBryan McClellanAndrew J. Brenner Preclinical study 24 April 2021 Pages: 375 - 386
Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer Neelima VidulaChristina YauHope S. Rugo Preclinical study 28 April 2021 Pages: 387 - 395
Circulating tumor cells, circulating tumor DNA, and disease characteristics in young women with metastatic breast cancer Ami N. ShahKristen J. CarrollMassimo Cristofanilli Preclinical study 02 June 2021 Pages: 397 - 405
The impact of high-intensity interval exercise training on NK-cell function and circulating myokines for breast cancer prevention among women at high risk for breast cancer Adriana M. ColettaNadia H. AghaRichard J. Simpson Clinical trial Open access 08 February 2021 Pages: 407 - 416
A propensity score-matched comparison of recurrence outcomes after immediate implant vs autologous flap reconstruction in patients receiving neoadjuvant chemotherapy for breast cancer Zhen-Yu WuHyun Ho HanBeomSeok Ko Clinical trial 19 March 2021 Pages: 417 - 425
Who is managing menopausal symptoms, sexual problems, mood and sleep disturbance after breast cancer and is it working? Findings from a large community-based survey of breast cancer survivors Michelle PeateChristobel SaundersMartha Hickey Clinical trial 11 February 2021 Pages: 427 - 435
The impact of age on patient-reported outcomes after oncoplastic versus conventional breast cancer surgery M. RitterB. M. LingE. A. Kappos Clinical trial Open access 19 February 2021 Pages: 437 - 446
Prognostic value of p53 expression in hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer patients receiving neoadjuvant chemotherapy Loai Saleh AlbinsaadJisun KimSae Byul Lee Clinical trial 18 February 2021 Pages: 447 - 454
Direct comparison of three different mathematical models in two independent datasets of EUSOMA certified centers to predict recurrence and survival in estrogen receptor-positive breast cancer: impact on clinical practice Cristiana IacuzzoFabiola GiudiciMarina Bortul Clinical trial 01 March 2021 Pages: 455 - 465
Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study Sherko KuemmelCarlo A. TondiniMiguel Martín Clinical trial Open access 21 March 2021 Pages: 467 - 476
Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey Sharon McGeeMashari AlzahraniMark Clemons Clinical trial 23 March 2021 Pages: 477 - 486
Examining the effect of obesity-associated gene variants on breast cancer survivors in a randomized weight loss intervention ThaiHien NguyenMelinda L. IrwinYasmmyn D. Salinas Clinical trial 06 March 2021 Pages: 487 - 497
Repeat breast-conserving treatment of ipsilateral breast cancer recurrence: a nationwide survey amongst breast surgeons and radiation oncologists in the Netherlands Coco J. E. F. WalstraRobert-Jan SchipperGrard A. P. Nieuwenhuijzen Clinical trial Open access 13 March 2021 Pages: 499 - 514
Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers Neda StjepanovicJan Lubinskithe Hereditary Breast Cancer Clinical Study Group Epidemiology 10 January 2021 Pages: 515 - 523
Early postoperative outcomes in implant, pedicled, and free flap reconstruction for breast cancer: an analysis of 23,834 patients from the ACS-NSQIP datasets Murad J. KaradshehRichard TyrellSameer A. Patel Epidemiology 19 January 2021 Pages: 525 - 533
Diagnostic value of radiomics and machine learning with dynamic contrast-enhanced magnetic resonance imaging for patients with atypical ductal hyperplasia in predicting malignant upgrade Roberto Lo GulloKerri VincentiKatja Pinker Epidemiology Open access 20 January 2021 Pages: 535 - 545
Comparison of the performance of four staging systems in determining the prognosis of breast cancer among women undergoing neoadjuvant chemotherapy Isabella Cristina Santos SoaresMarcelo Adeodato BelloLuiz Claudio Santos Thuler Epidemiology 08 January 2021 Pages: 547 - 555
Global, regional, national burden of breast cancer in 185 countries: evidence from GLOBOCAN 2018 Rajesh Sharma Epidemiology 30 January 2021 Pages: 557 - 567
Exploring provider- and practice-level drivers of cost-consciousness in breast cancer reconstruction—secondary analysis of a survey of the American Society of Plastic Surgeons Clifford C. SheckterOluseyi AliuAnaeze C. Offodile II Epidemiology 19 January 2021 Pages: 569 - 576
The increasing importance of histologic grading in tailoring adjuvant systemic therapy in 30,843 breast cancer patients C. van DooijeweertI. O. BaasE. van der Wall Epidemiology Open access 30 January 2021 Pages: 577 - 586
Allostatic score and its associations with demographics, healthy behaviors, tumor characteristics, and mitochondrial DNA among breast cancer patients Hua ZhaoRenduo SongJie Shen Epidemiology 28 January 2021 Pages: 587 - 596
Shall patients’ anxiety influence surgical decisions for atypical breast lesions? A substudy of the prospective NOMAT trial Flore SalviatCécile CharlesCatherine Uzan Letter to the Editor 12 March 2021 Pages: 597 - 599
Letter to the editor regarding: ‘Impalpable breast lesion localisation, a logistical challenge: results of the UK iBRA-NET national practice questionnaire’ Benjamin PatelLouise MerkerAjay Sahu Letter to the Editor 13 March 2021 Pages: 601 - 602
Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine Shayma KazmiDebanjana ChatterjeePeter A. Kaufman Correction Open access 27 April 2021 Pages: 603 - 603
